These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27053531)

  • 1. Ethical and regulatory aspects of genome editing.
    Kohn DB; Porteus MH; Scharenberg AM
    Blood; 2016 May; 127(21):2553-60. PubMed ID: 27053531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome editing primer for the hematologist.
    Hoban MD; Bauer DE
    Blood; 2016 May; 127(21):2525-35. PubMed ID: 27053532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Science and Bioethics of CRISPR-Cas9 Gene Editing: An Analysis Towards Separating Facts and Fiction.
    Cribbs AP; Perera SMW
    Yale J Biol Med; 2017 Dec; 90(4):625-634. PubMed ID: 29259526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical and regulatory issues in human gene editing: Chinese perspective.
    Lei R; Qiu R
    Biotechnol Appl Biochem; 2020 Nov; 67(6):880-891. PubMed ID: 33011985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.
    Dever DP; Porteus MH
    Curr Opin Hematol; 2017 Nov; 24(6):481-488. PubMed ID: 28806273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical application of gene editing: ethical and social issues.
    Ormond KE; Bombard Y; Bonham VL; Hoffman-Andrews L; Howard H; Isasi R; Musunuru K; Riggan KA; Michie M; Allyse M
    Per Med; 2019 Jul; 16(4):337-350. PubMed ID: 31331245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Genome Editing and Ethical Considerations.
    Krishan K; Kanchan T; Singh B
    Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical applications of genome editing in HIV.
    Wang CX; Cannon PM
    Blood; 2016 May; 127(21):2546-52. PubMed ID: 27053530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Customizing the genome as therapy for the β-hemoglobinopathies.
    Canver MC; Orkin SH
    Blood; 2016 May; 127(21):2536-45. PubMed ID: 27053533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans.
    Howard HC; van El CG; Forzano F; Radojkovic D; Rial-Sebbag E; de Wert G; Borry P; Cornel MC;
    Eur J Hum Genet; 2018 Jan; 26(1):1-11. PubMed ID: 29192152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building Capacity for a Global Genome Editing Observatory: Conceptual Challenges.
    Hurlbut JB; Jasanoff S; Saha K; Ahmed A; Appiah A; Bartholet E; Baylis F; Bennett G; Church G; Cohen IG; Daley G; Finneran K; Hurlbut W; Jaenisch R; Lwoff L; Kimes JP; Mills P; Moses J; Park BS; Parens E; Salzman R; Saxena A; Simmet H; Simoncelli T; Snead OC; Rajan KS; Truog RD; Williams P; Woopen C
    Trends Biotechnol; 2018 Jul; 36(7):639-641. PubMed ID: 29871776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene editing in human development: ethical concerns and practical applications.
    Rossant J
    Development; 2018 Jul; 145(16):. PubMed ID: 30045910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome Editing: Promoting Responsible Research.
    Hirsch F; Lemaitre C; Chneiweiss H; Montoliu L
    Pharmaceut Med; 2019 Jun; 33(3):187-191. PubMed ID: 31933285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should human germ line editing be allowed? Some suggestions on the basis of the existing regulatory framework.
    de Miguel Beriain I
    Bioethics; 2019 Jan; 33(1):105-111. PubMed ID: 30080925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legal issues regarding gene editing at the beginning of life: an EU perspective.
    De Miguel Beriain I
    Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. At the Heart of Genome Editing and Cardiovascular Diseases.
    Hernandez-Benitez R; Martinez-Martinez ML; Lajara J; Magistretti P; Montserrat N; Izpisua Belmonte JC
    Circ Res; 2018 Jul; 123(2):221-223. PubMed ID: 29976689
    [No Abstract]   [Full Text] [Related]  

  • 18. Ethical Considerations in the Manufacture, Sale, and Distribution of Genome Editing Technologies.
    Sugarman J; Shivakumar S; Rook M; Loring JF; Rehmann-Sutter C; Taupitz J; Reinhard-Rupp J; Hildemann S
    Am J Bioeth; 2018 Aug; 18(8):3-6. PubMed ID: 30133390
    [No Abstract]   [Full Text] [Related]  

  • 19. Kazuto Kato: the ethics of editing humanity.
    Bull World Health Organ; 2021 Sep; 99(9):616-617. PubMed ID: 34475598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.